Gericke N200 Nibbler Provides Size Reduction - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Gericke N200 Nibbler Provides Size Reduction


Pharmaceutical Technology
Volume 38, Issue 1, pp. 16
The N200 Pharma Nibbler offers a 200 mm diameter inlet and throughput of 1.500 (1/h), providing an alternative to hammer mills and more complex equipment for consistent size reduction of materials and agglomerates found in pharmaceutical production. Products enter the inlet either by a dump or controlled feed where a paddle assembly then rotates the product inside the size reduction chamber at a slow rotational speed. Attrition milling shears the product through the screen where it is discharged through the single outlet. The N200 Nibbler model features high capacity size reduction, a compact design, low power consumption and noise levels, minimum product temperature rise and fines generation, consistent particle size, and low rotational speed. It is suitable for glove box mounting and offers easy basket removal to provide improved access for cleaning.

Powder Technologies

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
27%
Attracting a skilled workforce
27%
Obtaining/maintaining adequate financing
14%
Regulatory compliance
32%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Report: Pfizer Makes $101 Billion Offer to AstraZeneca
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Source: Pharmaceutical Technology,
Click here